Russia says its Sputnik V coronavirus vaccine is 92 per cent effective at protecting people from COVID-19 according to interim trial results, as the global race for a vaccine accelerates to help end the pandemic that has claimed more 1.26 million lives worldwide.
Ottawa preparing to hire COVID-19 vaccine distributors for early possible rollout starting in January An analysis was conducted after 20 participants developed the novel coronavirus and examined how many had received the vaccine versus a placebo, the Russian Direct Investment Fund (RDIF), which has been backing the vaccine development, said on Wednesday.The results were based on data from the first 16,000 trial participants to receive both shots of the two-dose vaccine.“We are.